We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Global Call for Action Against Drug-Resistant Infections

By HospiMedica International staff writers
Posted on 31 Jan 2016
Print article
More than 80 leading international bodies came together to call on governments and industry to work in parallel and take comprehensive action against drug-resistant infections, as proclaimed in a joint declaration released at the World Economic Forum (Cologny, Switzerland), held during January 2016 in Davos (Switzerland).

The Declaration on Combating Antimicrobial Resistance, drafted and signed by 85 companies and nine industry associations across 18 countries, represents a major milestone in the global response to the challenges resulting from drug-resistant infections, with commercial drug and diagnostic developers for the first time agreeing on a common set of principles for global action to support antibiotic conservation and the development of new drugs, diagnostics, and vaccines.

Pharmaceutical, generics, diagnostics, biotechnology, and major industry companies called on governments around the world to go beyond existing statements of intent, and take concrete action. In particular, the declaration supports continuation of efforts for improved conservation of antibiotics, including a call for improved uptake of rapid point-of-care diagnostics to improve how antibiotics are prescribed. The declaration also calls for changes to incentive structures within health systems that directly reward doctors, pharmacists, and veterinarians for prescribing antibiotics in greater volumes.

The signatory companies also called on governments to work with them to develop new and alternative market structures that provide more dependable and sustainable models for antibiotics, and to commit the funds needed to implement them. These mechanisms are needed to provide appropriate incentives for companies to invest and overcome the formidable technical and scientific challenges of antibiotic discovery and development, including mechanisms that ensure that the pricing of antibiotics more adequately reflects the benefits they bring.

“This Declaration from industry is a major step forward in establishing a properly global response to the challenges of drug resistance,” said Lord Jim O’Neill, chairman of the UK Review on Antimicrobial Resistance. “I’m really impressed that such a wide range of companies have been able to agree on a common set of principles and commitments across these important issues; this is a level of consensus that we have not previously seen from the industry on this topic.”

“We are pleased to be part of this important initiative to combat antimicrobial resistance. Antimicrobials are the backbone of modern medicine, and have played a key role in increasing life expectancy globally,” said Paul Stoffels, MD, chief scientific officer and worldwide chairman of pharmaceuticals at Johnson & Johnson (JNJ; New Brunswick, NJ, USA). “Our long-standing commitment to innovation in antimicrobial R&D is evident through our legacy products and our new efforts to support ongoing research.”

Antimicrobial resistance is the natural process by which bacteria and other microbes develop resistance to the drugs commonly used to treat them, including antibiotic, antiviral, antiparasitic, and antifungal drugs.

Related Links:

World Economic Forum
Link to the Joint Declaration (PDF)
Johnson & Johnson


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Ultrasound Software
UltraExtend NX

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.